Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-067758

Interim CEO & General Counsel bought 1,000 shares at $6.44 ($6,440)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2022-06-01 Purchase +1,000 $6.44 $6,440 1,000 D: show line 1 in the form
Open-market purchases · 1,000 sh · avg $6.44 · $6,440
Loading xslF345X03/tm2217576d2_4seq1.xml…